Mark Offerhaus is the Chief Executive Officer and founder at Micreos BV, The Hague, Noord Holland, Netherlands. Mark is proud of the technologies at Micreos. He really thinks that the introduction of Staphefekt, the first endolysin for human use represents a real game changer. Nothing makes him happier than reading all the authentic user reviews of the product online.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)